Kola A - Search Results

1

Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis.

Kola A, Baensch M, Bautsch W, Hennecke M, Klos A, Casaretto M, Köhl J. Kola A, et al. Immunotechnology. 1996 Jun;2(2):115-26. doi: 10.1016/1380-2933(96)00425-3. Immunotechnology. 1996. PMID: 9373320

2

A selection system to study C5a-C5a-receptor interactions: phage display of a novel C5a anaphylatoxin, Fos-C5aAla27.

Hennecke M, Kola A, Baensch M, Wrede A, Klos A, Bautsch W, Köhl J. Hennecke M, et al. Among authors: kola a. Gene. 1997 Jan 15;184(2):263-72. doi: 10.1016/s0378-1119(96)00611-7. Gene. 1997. PMID: 9031638

3

Site-directed C3a receptor antibodies from phage display libraries.

Hawlisch H, Frank R, Hennecke M, Baensch M, Sohns B, Arseniev L, Bautsch W, Kola A, Klos A, Köhl J. Hawlisch H, et al. Among authors: kola a. J Immunol. 1998 Mar 15;160(6):2947-58. J Immunol. 1998. PMID: 9510199

4

A detailed analysis of the C5a anaphylatoxin effector domain: selection of C5a phage libraries on differentiated U937 cells.

Hennecke M, Otto A, Baensch M, Kola A, Bautsch W, Klos A, Köhl J. Hennecke M, et al. Among authors: kola a. Eur J Biochem. 1998 Feb 15;252(1):36-44. doi: 10.1046/j.1432-1327.1998.2520036.x. Eur J Biochem. 1998. PMID: 9523709 Free article.

5

Analysis of the C5a anaphylatoxin core domain using a C5a phage library selected on differentiated U937 cells.

Kola A, Baensch M, Bautsch W, Klos A, Köhl J. Kola A, et al. Mol Immunol. 1999 Feb;36(2):145-52. doi: 10.1016/s0161-5890(99)00019-x. Mol Immunol. 1999. PMID: 10378686

6

Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury.

Heller T, Hennecke M, Baumann U, Gessner JE, zu Vilsendorf AM, Baensch M, Boulay F, Kola A, Klos A, Bautsch W, Köhl J. Heller T, et al. Among authors: kola a. J Immunol. 1999 Jul 15;163(2):985-94. J Immunol. 1999. PMID: 10395696

7

A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.

Bautsch W, Kretzschmar T, Stühmer T, Kola A, Emde M, Köhl J, Klos A, Bitter-Suermann D. Bautsch W, et al. Among authors: kola a. Biochem J. 1992 Nov 15;288 ( Pt 1)(Pt 1):261-6. doi: 10.1042/bj2880261. Biochem J. 1992. PMID: 1445269 Free PMC article.

8

Functional activities of synthetic anaphylatoxic peptides in widely used biological assays.

Kola A, Klos A, Bautsch W, Kretzschmar T, Köhl J. Kola A, et al. Clin Exp Immunol. 1992 May;88(2):368-72. doi: 10.1111/j.1365-2249.1992.tb03090.x. Clin Exp Immunol. 1992. PMID: 1572104 Free PMC article.

9

Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome.

Stöve S, Welte T, Wagner TO, Kola A, Klos A, Bautsch W, Köhl J. Stöve S, et al. Among authors: kola a. Clin Diagn Lab Immunol. 1996 Mar;3(2):175-83. doi: 10.1128/cdli.3.2.175-183.1996. Clin Diagn Lab Immunol. 1996. PMID: 8991632 Free PMC article.

10

Circulating complement proteins in multiple trauma patients--correlation with injury severity, development of sepsis, and outcome.

Hecke F, Schmidt U, Kola A, Bautsch W, Klos A, Köhl J. Hecke F, et al. Among authors: kola a. Crit Care Med. 1997 Dec;25(12):2015-24. doi: 10.1097/00003246-199712000-00019. Crit Care Med. 1997. PMID: 9403752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters